Jasper Therapeutics (JSPR) Q2 2026 Earnings

14MayConfirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-1.74
-1.17
-0.61
-0.04

Details

Expected EPS
-0.48569
Actual EPS
-0.04
Surprise EPS
0.45
Surprise Percent
+91.76%

Description

Jasper Therapeutics (JSPR) has reported earnings of -0.04 per share for Q2 2026.

0 Comments

Share your thoughts